Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

PT-141

Bremelanotide, Vyleesi

Quick Stats
Studies 74
Trials 10
2020 pubmed

New Drugs 2020, part 2.

Hussar. Daniel A DA

Key Findings

  • Provides FDA‑approved indications for each drug
  • Lists precautions and adverse reaction profiles
  • Includes nursing considerations for clinical settings

Practical Outcomes

  • For biohackers interested in PT‑141, the review offers little actionable information. It’s mainly useful for clinicians rather than for designing personal protocols or dosing strategies.

Summary

The article is a clinical review of seven newly FDA‑approved drugs, describing their medical uses, safety warnings, side effects, and nursing care notes. It doesn’t give any specific guidance on using the peptide PT‑141 for self‑experimentation or performance enhancement.

Abstract

This article reviews seven drugs recently approved by the FDA, including indications, precautions, adverse reactions, and nursing considerations.

Study Information

Provider

pubmed

Year

2020

DOI

10.1097/01.nurse.0000659300.97243.8f